-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Eisai files for full FDA approval for Alzheimer's drug Leqembi

Reuters · 01/06/2023 23:37
Eisai files for full FDA approval for Alzheimer's drug Leqembi

- Japanese drugmaker Eisai Co Ltd 4523.T said on Saturday it had submitted an application to the U.S. Food and Drug Administration for a standard review of its Alzheimer's drug Leqembi, which was recently approved under the agency's accelerated review process.


(Reporting by Bhanvi Satija in Bengaluru; Editing by William Mallard)

((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))